Weight loss study for women in or after menopause
Part of Hormones & metabolism clinical trials.
This study tests an investigational drug called survodutide to see if it helps women who are overweight or obese and going through or finished menopause lose weight. If you qualify, you may receive the study drug or a placebo, and the study will track your weight loss over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman (assigned female at birth) and over 18 years old.
- You are overweight or obese.
- You are going through menopause or have already completed it.
- You have tried to lose weight through diet in the past but were not successful.
- You do not have type 1 or type 2 diabetes.
- You have not taken weight loss medication in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medicine called survodutide to help adults with overweight or obesity lose weight. If you have tried to lose weight before with diet but haven't had lasting success, you may be able to join.
This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.
This trial compares two different versions of an injected study drug (survodutide) to see how they are absorbed by the body. It is open to healthy people and people with overweight or obesity, and it may help researchers find a better way to deliver this treatment.
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
This study tests an investigational medicine for weight loss in people with excess weight. It aims to see how effective the medicine is and may help you lose weight and improve health.
This study tests a GLP-1 agonist medication (like Ozempic) to help postmenopausal women lose weight and improve physical and blood vessel health. It focuses on women aged 46–60 with obesity.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.